Quality of life is an important outcome measure in patients with end-stage heart failure waiting for heart transplantation. The purpose of this study was to investigate the relationship between aspects of quality of life and physiological and psychosocial variables in patients with end-stage heart failure. A total of 123 patients participated in the study. The functional status was assessed with New York Heart Association (NYHA) functional classifi cation, a 6-minute walk test (6 MWT) and peak oxygen uptake (pVO 2 ). Health related quality of life (HRQOL) was measured with Medical Outcomes Study, 36-item Short Form Survey (SF-36), and Minnesota Living with Heart Failure Questionnaire (MLHFQ). Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI) were used to assess psychological symptoms. A signifi cant relationship was found between HRQOL (SF-36 and MLHFQ) and functional status (NYHA, 6 MWT and pVO 2 ) ( p < 0.05). Psychological symptoms (BDI) were associated with HRQOL ( p < 0.05). In addition to clinical derangements, functional limitation and psychological distress can lead to limitations in activities of daily life through impairment of quality of life. It would be helpful to evaluate psychological symptoms and quality of life in patients with end-stage heart failure besides routine clinical evaluations.
Tohoku J. Exp. Med., 2008 , 214 (1), 17-25. © 2008 Although surviving heart failure (HF) can be prolonged through advances in medical treatment, end-stage HF still has poor prognosis and annual mortality of HF is still about 30% (Reis et al. 1997; Burns et al. 1997; Lowe et al. 1998) . Improving health related quality of life (HRQOL) is an important objective for treatment. Patients in the waiting list for heart transplantation demonstrate clinical deterioration, diffi culty in daily life activities, decrease in cognitive and social functioning and emotional well-being along with an increase in symptoms of anxiety and depression. However, quality of life is a multidimensional concept, based on the patient's own perception of his or her health and which includes not only the functional or physical dimensions of the disease, but also the psychological and social ones.
Decreased functional capacity and psycho-
MATERIALS AND METHODS

Study design and patients
A cohort of patients attending the Ege University Medical Faculty Cardiothoracic/Pre-transplant Clinic was recruited. Patients were referred to this clinic by cardiologists for management of their advanced HF and potential cardiac transplantation. Patients were recruited from the clinic over a 2-year period between December 2004 and December 2006. Study inclusion criteria were: to be in the transplant list for at least 6 months, to be able to understand and speak Turkish, to be free of any psychiatric disease, to be stable in exercise tests and to volunteer for participating in the study. Heart transplant candidates were enrolled in the waiting list after undergoing a mental examination by a psychiatry team before transplant decision was made. Hence, all patients were those who had undergone such psychiatric examinations. Patients with history of psychiatric disorders and those who were diagnosed with any psychiatric disorder following the tests and interviews were excluded from the study. Each volunteer gave their written consent to participate in this study.
Patients with neurological, orthopedic, peripheral vascular or severe pulmonary disease and who would have been unable to take the exercise test and NYHA Classifi cation class IV patients were excluded from the study. NYHA class IV patients were excluded due to the diffi culty of performing the cardiopulmonary exercise test.
Standard medical treatment was individually optimized and unaltered. Sociodemographic and clinical characteristics were obtained through patient interview and medical record review. Sociodemographic data collected were age, gender, marital status, educational level, employment, and cigarette smoking. Clinical data included NYHA classifi cation, HF etiology, right and left ventricular ejection fraction (RVEF and LVEF), body mass index (BMI), and concomitant disease (hypertension, hypercholesterolemia, diabetes). Pulmonary function test (forced expiratory volume in one second [FeV1 %]) was performed and the ratio of the forced expiratory volume in the fi rst one second to the forced vital capacity (FeV1/FVC %) was calculated.
A total of 248 patients attended the Ege University Medical Faculty Cardiothoracic/Pre-transplant Clinic over the 2-year recruitment period. One hundred and fi fty six patients have met the inclusion criteria. Twenty fi ve patients withdrew their consent after enrollment. Eight patients were excluded from the study because they logical deterioration in end-stage HF patients may have a negative impact on the quality of life (Zipfel et al. 1998) . Functional inability to perform activities is one of the most common problems in patients with HF (Jeng et al. 2004) . Functional impairment has a stronger association with quality of life in HF patients than cardiac function does (Carels 2004) .
HF patients show signifi cant levels of depression in 21.5% of cases and anxiety in 27% of cases (Zipfel et al. 1998 ) and according to New York Heart Association (NYHA) Classifi cation, depression increases as the disease progresses (11% in class I vs 42% in class IV) (Rutledge et al. 2006) . Negative infl uence of psychological distress in HF patients (Zipfel et al. 1998; Rumsfeld et al. 2003; Carels 2004) , and increased risk of post-transplantation mortality have been observed among patients with preoperative depression (Triffaux et al. 2001) .
Thus, treatment of HF needs to focus on increasing the quality of life along with prolonging survival. The discrepancy between the physician's objective assessment and the patient's perception suggests that clinical indices may not entirely refl ect the effectiveness of the treatment from the patients' perspective (Mitani et al. 2003) . Assessment of the HRQOL is a promising tool and may help physicians to assess the patients' clinical status from the patients' point of view.
As mentioned above, quality of life is an important parameter in patients with end-stage heart disease waiting for heart transplantation. Although there are studies in the literature analyzing the association of clinical parameters with the quality of life in patients with HF, there are few studies investigating quality of life and clinical conditions, in terms of functional capacity and psychological symptoms in patients with endstage HF (Molzahn et al. 1997; Zipfel et al. 1998; Rocci et al. 2004) .
The aim of this study was to understand the relationship among clinical parameters, functional capacity, psychological symptoms and HRQOL.
did not answer all of the questions. The remaining 123 patients were included in the study.
Clinical assessments
The following assessments were performed for all of the subjects. . This is one of the most widely used scales evaluating quality of life. The SF-36 explores eight dimensions of the quality of life "physical function", "physical role", "bodily pain", "general health", "vitality", "social function", "emotional role" and "mental health". All scales were linearly transformed to a 0 to 100 scoring, with 100 indicating most favorable health state and 0 indicating the least favorable health state (Medical outcomes Trust 1994; Koçyiğit et al. 1999; Sidorov et al. 2003) .
HRQOL assessment a) Medical Outcomes Study 36-item Short Form Survey
b) Minnesota living with heart failure questionnaire (MLHFQ). This questionnaire consists of 21 questions measuring the effects of symptoms specifi cally related to HF. Physical, emotional and total scores are identifi ed (Rector et al. 1987) . Each item ranged from 0 (no impairment) to 5 (very much impairment). Higher scores indicate that patients perceive more impairment (Rector and Cohn 1992) .
Functional status a) Cardiopulmonary exercise test.
The cardiopulmonary exercise test was performed on a treadmill (Treadmill model 770 CE), and there was continuous monitoring of the patient with electrocardiography (ECG). The exercise test was always conducted by the same member of the research team to ensure consistency. All of the patients were administered the modifi ed Naughton protocol (Patterson et al. 1972 ). Blood pressure measurements were taken every two minutes using a standard manometer (Sphygmomanometer, Erka, Germany). During the exercise test, oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were analyzed using a metabolic testing system (Masterscreen CPX, Viasys Heathcare, Jaeger, Würzburg, Germany) on a breath-by-breath basis from the patient's exhaled air, and the means of measurements taken every 30 sec were calculated. The test was terminated according to the guidelines described previously. The peak VO 2 (pVO 2 ) (ml/kg/min) values during the exercise test were recorded.
b) Six minute walk test (6 MWT). 6 MWT was per-
formed at least 4 hrs before cardiopulmonary exercise test. Participants walked up and down a 20-m hallway for a period of 6 min at their own pace. Patients were permitted to stop and rest and were instructed to continue walking as soon as they felt able to do so. The distance walked by each subject was recorded in meters (Guyatt et al. 1985; Demers et al. 2001) . c) NYHA. It is a clinically sound four grade system that classifi es the functional impairment of patients with HF (The Criteria Committee of the New York Association Inc. 1964). A higher grading indicates more functional impairment as caused by the cardiac disease. NYHA functional class was determined by an independent cardiologist.
Psychological symptoms a) Beck depression inventory (BDI).
It is a test frequently used to assess depressive symptoms in chronic diseases. It is comprised of 21 items, 8 of which investigate the somatic symptoms of depression (such as loss of appetite and diffi culty sleeping) and 13 of which address the cognitive-affective symptoms of depression (e.g., despair, social withdrawal). The BDI is scored as follows: 0-9: no symptoms; 10-16: mild depression; 17-29: moderate depression; and 30-63: severe depression (Beck et al. 1985; Hisli 1989) .
b) Spielberger's state-trait anxiety inventory (STAI).
It is a self-report assessment of anxiety. It is comprised of 2 separate scales, with 20 items per scale. The stateanxiety scale of the STAI consists of 20 questions that determine how the respondents feel at a certain time and under certain conditions. The trait-anxiety scale of the STAI assesses how the respondent feels in general (Spielberger et al. 1970; Le Compte and Öner 1976) .
This study was approved by the local ethics committee and written consents were obtained from all of the patients.
Statistics
Data were analyzed using "Statistical Package for Social Sciences (SPSS) version 15.0 software system for Windows". Means and standard deviations were calculated for the descriptive statistics and to analyze the continuous variables, while frequency distributions were employed to analyze the categorical variables. Assessment of cut-off points of STAI and BDI with data of quality of life was obtained through using independent T test. The one-way ANOVA method was used for comparing the means of more than two groups. Pearson's correlation analysis was performed to determine the correlation between quality of life (SF-36, MLHFQ) and other variables. The level of signifi cance was set at p < 0.05 for all of the analyses.
RESULTS
Demographic and clinical characteristics of the patients are shown in Table 1 RVEF was positively correlated with most of the subscales of SF-36 while being negatively correlated with most of the subscales of MLHFQ ( p < 0.05, Table 3 ).
FeV1 was positively correlated with some of the subscales of SF-36 and negatively correlated with physical score of MLHFQ ( p < 0.05, Table BMI, body mass index; LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction; FeV1 %, Forced expiratory volume in one second; FeV1/FVC %, the forced expiratory volume in the fi rst one second to the forced vital capacity; ACE inhibitor, angiotensin-converting enzyme inhibitor; AT1 inh, Angiotensin II type1 receptor.
3), FeV1 was also positively correlated with pVO 2 (r = 0.39, p < 0.05) and 6 MWT (r = 0.43, p < 0.05).
Although pVO 2 was correlated signifi cantly with most of the subscales of SF-36; it was negatively correlated with MLHFQ physical score and total score (Table 3 , p < 0.05).
Similarly 6 MWT had a signifi cant positive correlation with most of the subscales of SF-36, while being negatively correlated with MLHFQ physical score and total score (Table 3, p < 0.05).
When patients with NYHA 2 and NYHA 3
were compared, many of the subscales of SF-36 (physical functioning, role physical, bodily pain, vitality, and social functioning) were signifi cantly lower in NYHA 3 patients compared to NYHA 2 patients ( p < 0.05). There were no signifi cant differences between NYHA 2/3 and MLHFQ ( p > 0.05). BDI scores of HF correlated positively with all of the subscales of SF-36 and correlated negatively with all of the subscales of MLHFQ (Table  3 , p < 0.05). In the group with BDI 10, which indicates presence of depressive symptoms, all of the subscale scores of SF-36 decreased significantly and MLHFQ increased signifi cantly ( p < 0.05).
STAI trait correlated signifi cantly with some of the subscales of SF-36 and emotional and total score of MLHFQ ( Physical function score in SF-36 was positively correlated with 6 MWT (r = 0.48, p < 0.05) and pVO 2 (r = 0.39, p < 0.05), ( p < 0.05). Physical score of MLHFQ was negatively correlated with 6 MWT (r = −0.33, p < 0.05), and pVO 2 (r = −0.47, p < 0.05).
DISCUSSION
Our study demonstrated that clinical parameters, functional capacity and psychological symptoms are related to quality of life to variable extent in end-stage HF patients.
Our study did not reveal any correlation between demographic data and HRQOL. Similarly Westlake et al. could not demonstrate any correlation among life quality, sex and age (Westlake et al. 2002) . This was attributed to small number of females in the study and relatively younger age of the end-stage HF patients referred for heart transplantation. In our study, young males formed the majority of the patient group. In contrast, some studies found correlations between quality of life and demographic data (Grady et al. 1995; Gottlieb et al. 2004; Evangelista et al. 2005) . In their study Evangelista et al. (2005) found a restriction of SF36, Study 36-item short form survey; MLHFQ, Minnesota living with heart failure questionnaire; pVO 2 , peak VO 2 ; 6 MWT, Six minute walk test; NYHA, New York heart a s s o c i a t i o n c l a s s i fi c a t i o n ; B D I , b e c k depression inventory; STAI, Spielberger's state-trait anxiety inventory. both physical and mental health and an increase in depression in older female patients with endstage HF. On the other hand, Gottlieb et al. found that the incidence of depression was higher in women, young, and black patients with HF and this had a negative effect on the quality of life (Gottlieb et al. 2004) .
One of the pathology measures of HF, LVEF did not correlate with quality of life of HF patients in several studies (Juenger et al. 2002; Rector and Cohn 2006) . Similarly, we did not fi nd a signifi cant correlation between LVEF and quality of life. The few associations between quality of life and LVEF suggest that diminished cardiac function is not necessarily related to an unsatisfactory and diminished quality of life. To our best knowledge, there are no studies that demonstrate the relationship of RVEF to quality of life of HF patients. In our study, we found that RVEF is related to quality of life. We consider that functional capacity and symptoms are worse in HF patients if RVEF is affected (Kindman et al. 1994; La Vecchia et al. 2001 . This fi nding requires confi rmation from additional studies.
Patients with HF complain of breathlessness. Although pulmonary functions of HF patients show restrictive or obstructive characteristics most of HF patients have normal pulmonary function test results (Kindman et al. 1994; Clark 2000) . In addition, inspiratory muscle training has been shown to reduce dyspnea and increase the quality of life and functional status of HF patients due to increase in strength and endurance of respiratory muscles (McConnell et al. 2003; Skobel et al. 2005) . Russell et al. (1998) pointed out an association between pulmonary function tests and exercise capacity of HF patients, but Ingle et al. (2005) failed to demonstrate this association. Ingle et al. (2005) could not demonstrate an association between NYHA 3 and NYHA 4 patients in terms of pulmonary function tests and exercise capacity. In our study, FeV1 was related to both functional capacity tests and physical function subscale of quality of life. We believe that cardiopulmonary rehabilitation programs should be prescribed to HF patients along with medical treatment to decrease dyspnea. In addition, there are no studies which investigated respiratory function tests and quality of life. In our study, respiratory function abnormalities were related to quality of life in all areas except physical function. As dyspnea affects physical, mental and also social aspect of an individual, we believe that rehabilitation is crucial for these patients. We believe that there is a need for additional research to confi rm this fi nding and provide a basis to change clinical practice.
Activity intolerance in patients with HF is a widespread problem. Exercise intolerance may infl uence quality of life in HF patients. HF patients with higher functional limitations show marked decreases in the physical scores of quality of life (Carels 2004; Jeng et al. 2004) . HF patients' daily activities and social lives are limited due to fatigue, dyspnea, pain and psychological distress which also decrease their physical capacity (Jeng et al. 2004) . Most of the studies show that functional capacity defi ciencies affect physical aspects of quality of life (Westlake et al. 2002; Carels 2004; Jeng et al. 2004; Myers et al. 2006) . Evangelista et al. (2005) found that function limitations had negative impact on the mental health and emotional well-being in the end-stage HF patients. Our study did not reveal any decrease in functional capacity among individuals who had depressive symptoms, either. We observed that functional capacity defi ciencies have a negative infl uence on physical parameters of the quality of life in end-stage HF patients; also, worsening of NYHA resulted in deterioration of the quality of life. Improvement of the functional capacity of HF patients should be an objective of physicians concerned with cardiopulmonary rehabilitation.
Percentage of depression in HF patients has been reported as 36-48% (Gottlieb et al. 2004; Friedmann et al. 2006 ) and anxiety has been reported as 45% (Friedmann et al. 2006) . Additionally mortality, complications, re-hospitalization and frequency of hospital presentations have been higher in HF patients with higher level of depression and anxiety (Friedmann et al. 2006; Rutledge et al. 2006) . Clinical conditions of graft rejection, infection and neoplasm may also impose psychological distress on HF patients (Evangelista et al. 2005) . In studies analyzing the relation of depression with quality of life, HF patients with depressive symptoms were observed to have lower scores in quality of life (Carels 2004) . Carels (2004) showed that depressive symptoms affected both physical and emotional aspects of quality of life. Physical infl uence on quality of life may bring limitations to the daily life activities of HF patients with depressive symptoms. Similarly, a decrease in the emotional life quality leads to negative mood, loss of control, nervousness and affects the family life negatively (Carels 2004) . Similar to other studies, depression was associated with physical and emotional subscales of the quality of life in patients with end-stage HF. Some studies demonstrated that anxiety also has an effect on quality of life of HF patients (Steptoe et al. 2000; Carels 2004 ). Steptoe et al. (2000) found that anxiety imposed an effect on quality of life to an extent. Lee et al. (2005) determined that high levels of anxiety and depression were most detrimental to health related quality of life in HF patients. In our study anxiety had similar effects on quality of life in end-stage HF patients in parallel with their fi nding. In our study depression and anxiety were related to quality of life of HF patients. Considering these results and other studies, psychological symptoms that are usually overlooked in this group of patients are in fact related to their quality of life. We believe that end-stage HF patients should be evaluated for this aspect, both preoperative and postoperative.
The small number of women involved in the study was a limitation of our study. Also it would be useful to follow these variables that were evaluated, for any alteration in the long-term during the pre-transplant period. Also the study population is small and very select (transplant candidates). Thus, these results are not generalizable to other HF patients. Another limitation might be the cross sectional design of this study. This design is limited in making casual interference of the identifi ed correlates on the emotional impairment. And also, the aim of this study was to determine those factors that have an effect on the quality of life in HF patients. Since the rationale of this study does not cover assessment of the relationship between psychological criteria and functional capacity, such data were not included in the study in order not to confuse the readers. There is a need for further studies that will explore the relationship between psychological criteria and functional capacity in HF patients.
As a result, quality of life is greatly impaired in patients with end-stage heart disease. In addition to clinical derangements, functional limitation and psychological distress can lead to limitations in the activities of daily life through impairment of the quality of life. It would be helpful to evaluate psychological symptoms and quality of life in patients with end-stage HF besides routine clinical evaluations. We believe that rehabilitative approaches that could increase respiratory and functional capacity and improve psychological symptoms would be quite beneficial in these patients for improving their quality of life and this hypothesis needs to be supported by future studies.
